Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / LMNX - Luminex bags BARDA award for filing respiratory panel that incudes SARS-CoV-2


LMNX - Luminex bags BARDA award for filing respiratory panel that incudes SARS-CoV-2

Luminex (LMNX) receives ~$5.4M award from the Biomedical Advanced Research and Development Authority or BARDA to conduct product development work and complete filing for Luminex's expanded NxTAG Respiratory Pathogen Panel.This includes the SARS-CoV-2 virus for high-throughput COVID-19 testing.Since the COVID-19 pandemic began, Luminex has been committed to expanding capacity for SARS-CoV-2 testing across all of its molecular platforms.Press Release

For further details see:

Luminex bags BARDA award for filing respiratory panel that incudes SARS-CoV-2
Stock Information

Company Name: Luminex Corporation
Stock Symbol: LMNX
Market: NASDAQ
Website: luminexcorp.com

Menu

LMNX LMNX Quote LMNX Short LMNX News LMNX Articles LMNX Message Board
Get LMNX Alerts

News, Short Squeeze, Breakout and More Instantly...